| abstract |
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na V n1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Na V n1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders. |